Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
9.73
-1.13 (-10.41%)
At close: Dec 20, 2024, 4:00 PM
9.98
+0.25 (2.57%)
After-hours: Dec 20, 2024, 6:53 PM EST

Jupiter Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
--0.230.641.13-
Revenue Growth (YoY)
---63.44%-43.35%--
Cost of Revenue
0.680.950.941.451.640.69
Gross Profit
-0.68-0.95-0.71-0.81-0.52-0.69
Selling, General & Admin
2.432.922.723.11.341.49
Operating Expenses
2.432.922.723.11.341.49
Operating Income
-3.12-3.87-3.43-3.91-1.85-2.18
Interest Expense
-0.25-0.22-0.74-0.11-0.01-0.32
Interest & Investment Income
000000
Other Non Operating Income (Expenses)
0.110.190.26-0.090.280.3
EBT Excluding Unusual Items
-3.26-3.9-3.91-4.11-1.58-2.2
Other Unusual Items
0.73-0.89-1.05-0.09-0.07-0.85
Pretax Income
-2.52-4.78-4.96-4.2-1.65-3.05
Net Income
-2.52-4.78-4.96-4.2-1.65-3.05
Net Income to Common
-2.52-4.78-4.96-4.2-1.65-3.05
Shares Outstanding (Basic)
272625242221
Shares Outstanding (Diluted)
272625242221
Shares Change (YoY)
3.55%3.75%6.69%9.51%5.01%-
EPS (Basic)
-0.09-0.18-0.19-0.18-0.08-0.15
EPS (Diluted)
-0.09-0.18-0.19-0.18-0.08-0.15
Free Cash Flow
-0.5-0.48-1.25-1.74-0.25-0.14
Free Cash Flow Per Share
-0.02-0.02-0.05-0.07-0.01-0.01
Gross Margin
----126.90%-45.74%-
Operating Margin
---1471.38%-612.36%-164.41%-
Profit Margin
---2125.15%-658.31%-146.92%-
Free Cash Flow Margin
---535.19%-271.94%-22.62%-
EBIT
-3.12-3.87-3.43-3.91-1.85-2.18
EBIT Margin
-----164.41%-
Source: S&P Capital IQ. Standard template. Financial Sources.